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Abstract We have studied functional properties of peptide
transport in the pheochromocytoma neuroendocrine cell line from
rat. The neutral peptide D-Phe-L-Ala (resistant to hydrolysis) is a
good substrate for uptake into these cells. Transport is
substantially inhibited by diethylpyrocarbonate pretreatment
and is stimulated by external acidification. It is sodium-
independent and, unexpectedly, insensitive to membrane poten-
tial. Peptide uptake is inhibited by a wide variety of other di- and
tripeptides but not by amino acids. The neuropeptide kyotorphin
(opioid dipeptide (L-Tyr-L-Arg)) inhibits uptake of labelled
peptide and trans-stimulates efflux showing that it is a
transported substrate. These findings are discussed in relation
to the molecular basis and physiological role of this transport
system. ß 2001 Published by Elsevier Science B.V. on behalf
of the Federation of European Biochemical Societies.
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1. Introduction
It is well recognized that small peptides are absorbed into
epithelial cells [1] by one of the two members (PepT1 or
PepT2) of the H/oligopeptide transporter family (see [2] for
review). Peptide transport in neurons or endocrine cells is less
well studied. For example, it is not clear how peptide break-
down fragments produced from biologically active small neu-
ropeptides in the central nervous system are removed from the
interstitial £uid.
In a preliminary study, we reported peptide transport activ-
ity in neuroendocrine cells [3]. In the present study, we have
systematically examined whether the biologically active kyo-
torphin (L-Tyr-L-Arg), an endogenous opioid [4], also interacts
with the peptide transporter (PepT) in neuroendocrine cells as
it does in brain synaptosomes [5]. A rat pheochromocytoma
cell line (PC12) has therefore been used as a model to explore
and screen for endogenous PepTs.
2. Materials and methods
2.1. Chemicals
Hydrolysis resistant D-[3H]Phe-L-Ala was custom-synthesized com-
mercially (Zeneca, Northwick, Cheshire, UK). Kyotorphin was
bought from Bachem Ltd. (UK). All other chemicals were of high
analytical grade purchased from Sigma (UK) unless otherwise stated.
2.2. Cell culture
PC12 cells (passage 30^49) were maintained in 75 cm2 £asks in
complete RPMI 1640 (Gibco Life Technologies, UK) medium supple-
mented with 10% heat-inactivated horse serum, 5% fetal bovine se-
rum, 4 mM glutamine and 175 Wg/ml gentamicin at 37‡C in a 5% CO2
and 95% air environment as described previously [6].
2.3. Flux studies
Prior to transport experiments, adherent cells were detached from
culture £ask by 1 min treatment with an EDTA/trypsin (containing
0.05% w/v porcine trypsin and 0.02% w/v EDTA) solution at 37‡C.
Cells were resuspended and washed/centrifuged (1200 rpm) twice for 5
min in excess PBS (without Mg2 and Ca2) at room temperature.
Cells were then resuspended in complete medium (see above) and cell
number and viability was assessed by trypan blue exclusion. Cells
were plated and grown in 12-well plates at initial density of 500 000
cells/well in 2 ml complete medium. Fresh medium was added 1 day
prior to the £ux experiments.
2.3.1. In£ux experiments. Transport experiments were carried out
on cells that had become fully con£uent (at 4 days in culture). Prior to
uptake experiments, cells were washed and incubated in RPMI 1640
medium (4 mM glutamine but with serum absent) for 1 h at 37‡C in a
5% CO2 and 95% air environment. Following this step, cells were
equilibrated (5^10 min, 37‡C) in HEPES-bu¡ered Krebs (pH 7.4).
The Krebs composition was (in mM): 120 NaCl, 4.5 KCl, 1 MgSO4,
1.25 CaCl2, 10 glucose bu¡ered with either 25 HEPES or 29 MES.
The initial rate of uptake of the hydrolysis-resistant peptide [3H]D-
Phe-L-Ala (420 nM, speci¢c activity 10 Ci/mmol) was determined at
37‡C in the absence or presence of potential competing substrates.
Uptake was rapidly stopped by quick aspiration and cells were
washed three times in 3 ml ice-cold Krebs (pH 5.5 or 7.4) to remove
remaining extracellular radioactivity and the cells dissolved in 1 ml (1
M) NaOH. Aliquots were then taken for scintillation counting. All
experiments were performed at pH 5.5 (MES-bu¡ered Krebs) unless
otherwise stated. Non-speci¢c uptake (i.e. 0 s) was subtracted from all
data points, this was typically less than 10% of the mediated uptake.
2.3.2. E¥ux experiments. Cells were preloaded with [3H]D-Phe-L-
Ala (420 nM, speci¢c activity 10 Ci/mmol) for 30 s at pH 5.5 (37‡C)
and then washed three times in 3 ml Krebs (pH 5.5) at room temper-
ature to remove any remaining extracellular radioactivity. The e¥ux
of labelled dipeptide was initiated by the addition of isotope-free so-
lutions with or without unlabelled peptide substrate. The reaction was
rapidly stopped at di¡erent time points by quick aspiration. The cell
radioactivity in each well was determined as described above.
2.3.3. Diethylpyrocarbonate (DEPC) pretreatment. Immediately
before the uptake experiment, DEPC was made up fresh in Krebs
from a working stock (100 mM in 50% ethanol) kept at 4‡C. Cells
in each well were treated with 1 ml of DEPC (1 mM) for 10 min at
room temperature on a slow speed shaker plate. In control cells, 0.1%
ethanol was added as a vehicle for DEPC. After pretreatments, cells
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were washed once in 2 ml of Krebs (pH 5.5) at room temperature and
immediately placed in a water bath (37‡C) for the transport experi-
ment.
2.3.4. Protein determination. Protein concentration of cells in each
well was determined using the BCA Protein Assay kit with bovine
serum albumin as a standard (Pierce, Rockford, IL, USA).
2.4. mRNA analysis
mRNA analysis was carried out using RT-PCR as described by [7]
using rat speci¢c primers for PepT1, PepT2, PHT 1, PHT 2 and
GAPDH as summarized in Table 1. RNA samples were treated
with DNase I prior to RT-PCR to remove any contaminating
DNA. One microgram RNA was reverse transcribed into cDNA us-
ing an oligo(dT)12ÿ18 primer. The reverse transcription reaction was
sequentially incubated at 25‡C for 10 min, at 42‡C for 50 min and at
70‡C for 15 min, and then cooled on ice. The synthesized cDNA was
used for PCR ampli¢cation. The PCR conditions were: 94‡C for
1 min, 60‡C for 1 min and 72‡C for 2 min; then 30 cycles for
PepT1, 40 cycles for PepT2, PHT1 and PHT2, and 25 cycles for
GAPDH of 94‡C for 1 min, 60‡C for 1 min and 72‡C for 2 min;
followed by a 10 min ¢nal extension at 72‡C. To check for DNA
contamination, reactions were run with or without RNA in the ab-
sence of the reverse transcriptase and revealed no ampli¢ed product
(data not shown). PCR products were separated on a 2% agarose gel.
Gels were stained with ethidium bromide.
2.5. Statistical analysis
The e¡ects of inhibitors of peptide in£ux was determined by a t-
test. Statistical signi¢cance was taken at the 5% level. The (n) number
represents the number of wells examined in each experimental con-
dition. For e¥ux experiments, the time course was ¢tted by a mono-
exponential ¢t using Sigma Plot and statistical analysis of the rate
constants for e¥ux was determined.
3. Results
Fig. 1 shows the time course of uptake of labelled dipeptide
into PC12 cells over a period of 30 s at 37‡C. The e¡ects of
pre-exposure of the cells to DEPC on the time course of pep-
tide in£ux is also shown. It is apparent that the rate of entry is
linear over time for up to 30 s and that DEPC pretreatment
strongly inhibits in£ux. In the presence of DEPC, the rate was
reduced to approximately 20% of that in the control.
Fig. 2 shows that D-Phe-L-Ala uptake is stimulated by ex-
ternal acidi¢cation (the rate of in£ux at pH 5.5 is some four-
fold greater than at pH 7.4). This e¡ect was not observed for
the DEPC-insensitive component. At each external pH, there
is no signi¢cant di¡erence in the rate of peptide entry when
the cells are exposed to high KCl (isotonically replaced by
Table 1
Rat primers used for RT-PCR in cultured PC12 cells
Rat gene Oligonucleotide sequence Nucleotide number Product size (bp)
PepT1
Sense: 5P-GCGAGGTGGTCTTCTCTGTC-3P 1838^1858 444
Anti-sense: 5P-TCTCCAGGCAAGGACTCTGT-3P 2261^2281
PepT2
Sense: 5P-ACCTTGTCATTTACCGGCTG-3P 1239^1259 260
Anti-sense: 5P-AAAAGAGCTGACGGACTCCA-3P 1478^1498
PHT1
Sense: 5P-TGGAGCATTAATTTGGGAGC-3P 653^673 381
Anti-sense: 5P-CACAATCTTGACCAGGGCTT-3P 1013^1033
PHT2 (accession number AB026665)
Sense: 5P-AATCTGGGTGCCATTCTGTC-3P 728^748 379
Anti-sense: 5P-CACAAGGGTCACCATCACAG-3P 1086^1106
GAPDH
Sense: 5P-GGTGATGCTGGTGCTGAGTA-3P 264^283 304
Anti-sense: 5P-CCACAGTCTTCTGAGTGGCA-3P 570^589
Fig. 1. Time course of D-[3H]Phe-L-Ala (420 nM) in£ux into cul-
tured PC12 cells. Uptake was determined at pH 5.5 and at 37‡C in
cells that had (open circles) or had not (closed circles) been subject
to pretreatment with DEPC (1 mM). The error bars show mean þ
S.E.M. for n = 3^4 for each data point.
Fig. 2. In£ux over 30 s of D-[3H]Phe-L-Ala (420 nM) into cultured
PC12 cells at pH 5.5 and 7.4 in the presence or absence of 45 mM
K. Open bars show in£ux into cells pretreated with DEPC (1 mM)
and closed bars show in£ux in untreated control cells. This ¢gure
also shows in£ux over 30 s of D-[3H]Phe-L-Ala (420 nM) into cul-
tured PC12 cells at pH 5.5 in the presence (far left closed bar) or
absence (choline substitution; far right closed bar) of Na. The
data are shown as mean þ S.E.M. for n = 3 where *P6 0.05
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NaCl). This suggests that transport of peptide is not in£u-
enced by membrane depolarization. As also shown in Fig. 2,
peptide transport is not altered by sodium removal (isotoni-
cally replaced by choline). This suggests that peptide transport
is sodium independent.
Fig. 3 shows that the stimulation of transport by external
acidi¢cation is near maximal at pH 6.5.
Fig. 4 shows the inhibitory e¡ects of a number of compet-
ing substrates on labelled dipeptide in£ux. Both di- and tri-
peptides at 1 mM are e¡ective inhibitors (Fig. 4a). The amino
acid sequence within a given peptide appears to in£uence
quantitatively the ability of that unlabelled peptide to inhibit
in£ux. For example, at equimolar concentration Gly-Tyr is
less potent than Tyr-Gly. In addition to natural di- and tri-
peptides, a peptide space mimic (4-amino methylbenzoic acid
[8]) is also an e¡ective inhibitor. A number of naturally occur-
ring compounds are also able to inhibit peptide in£ux (Fig.
4b). Antibiotics (ampicillin and cephapirin), bioactive peptides
(formylmethionylarginylphenylalanyl amide and thyrotropin
releasing hormone (L-Glu-His-Pro amide)) and kyotorphin
(an opioid dipeptide) are all e¡ective inhibitors. Strikingly,
at equimolar concentration, the amino acid constituents of
the kyotorphin molecule (Tyr+Arg) were ine¡ective.
The DEPC-sensitive component of peptide in£ux was in-
hibited in a concentration-dependent way by kyotorphin.
The concentration of peptide giving half maximal inhibition
was 0.35 þ 0.08 mM (mean þ S.E.M., n = 3^7) (Fig. 5). In con-
trast, there was minimal inhibition of the DEPC-insensitive
£ux by kyotorphin.
Because of the inhibitory e¡ect of this biologically active
peptide (which is known to be synthesized in adrenal medulla)
[4], we wished to discover whether this molecule was itself a
substrate for the PepT. Fig. 6 shows the results of an e¥ux
assay. Addition of unlabelled kyotorphin trans-stimulated the
exit of labelled peptide from preloaded PC12 cells. The rate
constant for peptide e¥ux is 8.7 þ 1.9 in the absence and
61.7 þ 22U1033 s31 (n = 3) in the presence of 5 mM kyotor-
phin. This is proof that kyotorphin is a translocated substrate.
Figure 6b shows that kyotorphin but not its constituent ami-
no acids stimulates labelled peptide e¥ux in a concentration-
dependent manner with a Kt (0.95 þ 0.37 mM, mean þ S.E.M.,
n = 3) similar to the concentration of kyotorphin giving half
maximal inhibition of DEPC-sensitive D-Phe-L-Ala in£ux
(Fig. 5).
Fig. 7 shows that PepT1 but not PepT2, PHT1 or PHT2
mRNA is detected with the predicted product size (444 bp) by
RT-PCR. Immunocytochemistry however, using an anti-rat
C-terminal PepT1 antibody [9] revealed no immunoreactivity
in PC12 cells (data not shown).
4. Discussion
These functional studies suggest that there is a PepT in
PC12 cells. This transporter, however, has some features
Fig. 3. In£ux over 30 s of D-[3H]Phe-L-Ala (420 nM) into cultured
PC12 cells at di¡erent external pH. Data are shown as mean þ
S.E.M. for n = 3 where *P6 0.03 and **P6 0.01 compared with in-
£ux at pH 5.5.
Fig. 4. A: 30 s uptake (normalized to control) of DEPC-insensitive
D-[3H]Phe-L-Ala (420 nM) £ux into cultured PC12 cells at pH 5.5 in
the presence or absence of di- and tripeptides (all at 1 mM). The
data are shown as mean þ S.E.M. for n = 3^6 for each inhibitor
tested with *P6 0.05, **P6 0.02 and ***P6 0.01 compared with
control sample (4-AMBA, 4-amino methylbenzoic acid). B: 30 s up-
take (normalized to control) of DEPC-insensitive D-[3H]Phe-L-Ala
(420 nM) £ux into cultured PC12 cells at pH 5.5 in the presence or
absence of biologically active peptides (all at 1 mM with the excep-
tion of kyotorphin and its constituent amino acids (Tyr+Arg), both
of which were used at 5 mM). (FMRF, formylmethionylarginylphe-
nylalanyl amide.) The data are shown as mean þ S.E.M. for n = 3
for each inhibitor tested where *P6 0.05, **P6 0.02 and
***P6 0.01 compared with in£ux in control cells. The in£ux in the
presence of kyotorphin was signi¢cantly lower (#P6 0.01) compared
with that in the presence of its constituent amino acids Tyr+Arg.
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that are unexpected, speci¢cally the ¢nding that peptide trans-
port is electroneutral (see Fig. 8). This is in contrast to the
well-studied electrogenic properties of currently known PepTs
[10]. In other respects, however, the system we describe here
has obvious similarities to PepT1 and PepT2. It is stimulated
by external acidi¢cation and this stimulation is abolished
(data not shown) by a proton ionophore (carbonyl cyanide
p-tri£uoromethoxyphenylhydrazone); it is sodium-indepen-
dent and DEPC-sensitive (a well-known histidine modi¢er
that e¡ectively inhibits epithelial peptide transport [11]).
Moreover, small peptides (di- and tripeptides) appear to be
substrates, whereas amino acids are not. The high micromolar
substrate a⁄nity suggests greater similarity to PepT1 than
PepT2.
In addition to PepT1 and PepT2, a novel transporter was
recently identi¢ed [12]. This transporter (PHT1) was unusual
in that in addition to peptides it also translocated the amino
acid histidine. Our transporter is not PHT1 since we have
measured labelled histidine in£ux into PC12 cells in the pres-
ence or absence of 5 mM unlabelled kyotorphin. No inhibi-
tion of amino acid in£ux was observed (80 þ 17 in the absence
compared to 77 þ 7 fmol/mg protein/30 s in the presence of
5 mM unlabelled kyotorphin (mean þ S.E.M., n = 3)). More-
over, neither PHT1 nor PHT2 mRNAs are expressed in PC12
cells.
A further member of the PepT family is PepT3 (human)/
cI-1 (mouse macrophage). This molecule has been identi¢ed
through in silico genomics (accession number AB026665)
but not characterized functionally. The expression of this
transporter is induced by cAMP. However, again preliminary
experiments suggest that PepT3 is not the system we describe
since there was no change in the rate of peptide in£ux follow-
ing pharmacological stimulation. For example, after 1 h pre-
treatment with 500 WM CPT-cAMP, a membrane permeable
analogue of cAMP, the rate of D-Phe-L-Ala in£ux was
568 þ 64 compared to 593 þ 36 fmol/mg protein/30 s in the
absence of stimulation (mean þ S.E.M., n = 3). The most likely
explanation for our functional ¢ndings is that PC12 cells ex-
press a variant of PepT1 which lacks the C-terminal 18 amino
acids and which also has a catalytic cycle that is electroneu-
tral. This proposal needs further experimental analysis.
Functionally, why might PepTs be expressed in neuroendo-
crine cells? It is interesting that the endogenous PepT found in
this cell line is able to translocate the biologically active neu-
ropeptide kyotorphin. This peptide is synthesized [4] in the
adrenal medulla and up until now its neural release has
been assumed to be by exocytosis. An alternative explanation
for the mechanism of kyotorphin release is by reversed uptake
(cf. Fig. 6). Additionally and alternatively, PepT expression in
adrenal medulla may be required for neuropeptide uptake and
metabolism as elsewhere in both the central [5] and peripheral
Fig. 5. In£ux over 30 s of D-[3H]Phe-L-Ala (420 nM) into cultured
PC12 cells in the presence of di¡erent concentrations of substrates
either unlabelled kyotorphin (triangles) or its constituent amino
acids Tyr+Arg (circles). Filled symbols represent uptake in the ab-
sence of, and open symbols represent uptake following, pretreatment
with DEPC (1 mM). The data are shown as mean þ S.E.M. for
n = 3^6 for each data point. The rate of uptake in control samples
was 335 þ 35 fmol/mg protein/30 s.
Fig. 6. A: D-[3H]Phe-L-Ala (fmol/mg protein) remaining in PC12
cells preloaded with labelled peptide (420 nM) following e¥ux into
a medium with (¢lled symbols) or without (open symbols) 1 mM
kyotorphin. The data are shown as mean þ S.E.M. for n = 3 for each
data point. Lines of best ¢t for a monoexponential e¥ux have been
generated (Sigma Plot) and the rate constants describing these lines
are shown. B: Stimulation of labelled D-Phe-L-Ala e¥ux by increas-
ing concentration of kyotorphin (top plot) but not its constituent
amino acids (bottom plot).
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[13] nervous systems. The neuropeptide nerve growth factor
(NGF) is known to stimulate di¡erentiation of PC12 cells
towards a sympathetic neuronal phenotype. Initial experi-
ments with NGF (50 ng/ml) showed that such di¡erentiation
had no detectable e¡ect on the functional properties of this
PepT.
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Fig. 7. Ethidium bromide-stained agarose gel showing RT-PCR
products ampli¢ed from cultured rat PC12 cells. Molecular weight
markers are shown on the left (lane 1) followed by mRNA products
for rat PepT1, PepT2, PHT1, PHT2 and GAPDH (lanes 2,3,4,5 and
6, respectively). The expected band size of GAPDH was 304 bp
(dotted arrow) and that for PepT1 was 444 bp (thick arrow).
Fig. 8. Schematic diagram of peptide transport in PC12 cells. In the
upper panel, cotransport of proton and peptide is accompanied by
symport with an anion (X3) ; in the lower panel, cotransport of
proton and peptide is accompanied by antiport of cation (X).
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